Interventions to improve oral medication adherence in psychosis: The role of adherence measurement

Neuropsychiatry

Volumn 1, Issue 4, 2011, Pages 361-369

  Roberts, David L ^a   Fredrick, Megan M ^a   Carr, Heather N ^a   Velligan, Dawn I ^a  

^a University of Texas Health Science Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PSYCHOTROPIC AGENT;

BEHAVIOR THERAPY; FAMILY THERAPY; HUMAN; MEDICAL RESEARCH; MOTIVATION; PATIENT COMPLIANCE; PATIENT EDUCATION; PRIORITY JOURNAL; PROFESSIONAL PRACTICE; PSYCHOEDUCATION; PSYCHOPHARMACOTHERAPY; PSYCHOSIS; REVIEW;

EID: 84876510385     PISSN: 17582008     EISSN: 17582016     Source Type: Journal    
DOI: 10.2217/npy.11.37     Document Type: Review

References (53)

1. Thornley B, Adams C. Content and quality of 2000 controlled trials in schizophrenia over 50 years. BMJ 317, 1181-1184 (1998). (Pubitemid 28488506)
2. Breen R, Thornhill JT. Noncompliance with medication for psychiatric disorders. Reasons and remedies. CNS Drugs 9, 457-471 (1998). (Pubitemid 28293698)
3. Lacro JP, Dunn LB, Dolder CR, Leckband SG, Jeste DV. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. J. Clin. Psychiatr. 63, 892-909 (2002). (Pubitemid 35231730)
4. Terkelsen KG. Measuring the costs of schizophrenia. Implications for the post-institutional era in the US. Pharmacoeconomics 8, 199-222 (1995).
5. Weiden PJ. Cost of relapse in schizophrenia. Schizophr. Bull. 21, 419-429 (1995).
6. Zygmunt A, Olfson M, Boyer CA, Mechanic D. Interventions to improve medication adherence in schizophrenia. Am. J. Psychiatry 159(10), 1653-1664 (2002).
7. Dolder CR, Lacro JP, Leckband S, Jeste DV. Interventions to improve antipsychotic medication adherence: review of recent literature. J. Clin. Psychopharmacol. 23(4), 389-399 (2003). (Pubitemid 36951182)
8. Nose, M, Barbui C, Gray R, Tansella M. Clinical interventions for treatment non-adherence in psychosis: meta-analysis. Br. J. Psychiatry 183, 197-206 (2003). (Pubitemid 37070173)
9. Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence. Cochrane Database Syst. Rev. 2, CD000011 (2008).
10. Fenton WS, Blyler CR, Heinssen RK. Determinants of medication compliance in schizophrenia: empirical and clinical findings. Schizophr. Bull. 23(4), 637-651 (1997). (Pubitemid 27485972)
11. Velligan DI, Lam YF, Glahn DC et al. Defining and assessing adherence to oral antipsychotics: a review of the literature. Schizophr. Bull. 32(4), 724-742 (2006). (Pubitemid 44412860)
12. Velligan DI, Diamond P, Glahn DC et al. Relationships among subjective and objective measures of adherence to oral antipsychotic medications. Psychiatr. Serv. 58(9), 1187-1192 (2008). (Pubitemid 47507958)
13. Terrier N, Wykes T. Is there evidence that cognitive behaviour therapy is an effective treatment for schizophrenia? A cautious or cautionary tale? Behav. Res. Ther. 42, 1377-1401 (2004). (Pubitemid 39410355)
14. Amador XF, Flaum M, Andreasen NC et al. Awareness of illness in schizophrenia and schizoaffective and mood disorders. Arch. Gen. Psychiatry 51(10), 826-836 (1994). (Pubitemid 24313308)
15. Koren D, Seidman LJ, Goldsmith M, Harvey PD. Real-world cognitive-and metacognitive-dysfunction in schizophrenia: a new approach for measuring (and remediating) more "right stuff ". Schizophr. Bull. 32(2), 310-326 (2006).
16. Atkinson M, Zibin S, Chuang H. Characterizing quality of life among patients with chronic mental illness: a critical examination of the self-report methodology. Am. J. Psychiatry 154(1), 99-105 (1997). (Pubitemid 27020200)
17. Battle EH, Halliburton A, Wallston KA. Self medication amoung psychiatric patients and adherence after discharge. J. Psychosoc. Nurs. Men. Health Serv. 20, 21-28 (1982).
18. Boczkowski JA, DeSanto N. Neuroleptic compliance among chronic schizophrenic outpatients: An intervention outcome report. J. Consult. Clin. Psychol. 53, 666-671 (1985). (Pubitemid 15248846)
19. Bond GR, Miller LD, Pensec M. Assertive community treatment and reference groups: an evaluation of their effectiveness for young adults with serious mental illness and substance abuse problems. Psychosoc. Rehabil. J. 15, 30-43 (1991).
20. Kelly GR. Medication compliance and health education among outpatients with chronic mental disorders. Med. Care 28, 1181-1197 (1990).
21. O'Donnell M, Parker G, Proberts M et al. A study of client-focused case management and consumer advocacy: the Community and Consumer Service Project. Aust. NZ J. Psychiatry 33(5), 684-693 (1999). (Pubitemid 29488164)
22. Solomon P, Draine J, Mannion E. The impact of individualised consultation and group workshop family education interventions in ill relative outcomes. J. Nerv. Men. Dis. 184, 252-255 (1996). (Pubitemid 26151705)
23. Velligan DI, Diamond P, Mueller J et al. The short-term impact of generic versus individualized environmental supports on functional outcomes and target behaviors in schizophrenia. Psychiatry Res. 168(2), 94-101 (2009).
24. Velligan DI, Diamond PM, Mintz J et al. The use of individually tailored environmental supports to improve medication adherence and outcomes in schizophrenia. Schizophr. Bull. 34(3), 483-493 (2008).
25. Zhang M, Wang M, Li J et al. Randomised control trial of family intervention for 78 first-episode male schizophrenic patients. An 18-month study in Suzhou, Jiangsu. Br. J. Psychiatry 165, 96-102 (1994). (Pubitemid 24259374)
26. Kemp R, Kirov G, Everitt B, Hayward P, David A. Randomised controlled trial of compliance therapy. 18-month follow-up. Br. J. Psychiatry. 172, 413-419 (1998). (Pubitemid 28204550)
27. Sellwood W, Barrowclough C, Tarrier N, Quinn J, Mainwaring J, Lewis S. Needs-based cognitive-behavioral family intervention for carers of patients suffering from schizophrenia: 12-month follow-up. Acta Psychiatr. Scand. 104, 346-355 (2001). (Pubitemid 34280551)
28. Barrowclough C, Tarrier N, Lewis S et al. Randomised controlled effectiveness trial of a needs-based psychosocial intervention service for carers of people with schizophrenia. Br. J. Psychiatry, 174, 505-511 (1997). (Pubitemid 29278684)
29. Razali SM. Subramaniam M. Psychosocial interventions for schizophrenia. J. Men. Health 9(3), 283-289 (2000). (Pubitemid 30479111)
30. Seltzer A, Roncari I, Garfinkel P. Effect of patient education on medication compliance. Can. J. Psychiatry 25, 638-645 (1980). (Pubitemid 11195893)
31. Garety PA, Craig TK, Dunn G et al. Specialised care for early psychosis: symptoms, social functioning and patient satisfaction: randomised controlled trial. Br. J. Psychiatry 188, 37-45 (2006). (Pubitemid 43021925)
32. Strang JSF, Moss IRH, Razani J, Boyd JL. The effects of family therapy on treatment compliance in schizophrenia. Psychopharmacol. Bull. 17(3), 87-88 (1981).
33. Guimon J. The use of group programs to improve medication compliance in patients with chronic diseases. Patient Educ. Couns. 26, 189-193 (1995).
34. Hudson TJ, Owen RR, Thrush CR, Armitage TL, Thapa P. Guideline implementation and patient-tailoring strategies to improve medication adherence for schizophrenia. J. Clin. Psychiatry 69(1), 74-80 (2008). (Pubitemid 351281999)
35. Kemp R Hayward P, Applewhaite G, Everitt B, David A. Compliance therapy in psychotic patients: a randomised controlled trial. BMJ 312, 345-349 (1996). (Pubitemid 26050038)
36. Staring AB, Van der Gaag M, Koopmans GT et al. Treatment adherence therapy in people with psychotic disorders: randomised controlled trial. Br. J. Psychiatry 197(6), 448-455 (2010).
37. Razali MS, Yahya H. Compliance with treatment in schizophrenia: a drug intervention program in a developing country. Acta Psychiatr. Scand. 58, 113-118 (1995).
38. Herz MI. Psychosocial treatment. Psychiatr. Ann. 26, 531-535 (1996). (Pubitemid 126631350)
39. Sands RG, Cnaan RA. Two models of case management: assessing their impact. Comm. Men. Health J. 30, 441-457 (1994).
40. Velligan DI, Weiden PJ, Sajatovic M et al. Strategies for addressing adherence problems in patients with serious and persistent mental illness: recommendations from the expert consensus guidelines. J. Psychiatr. Pract. 16(5), 306-324 (2010).
41. Gray R, Leese M, Bindman J et al. Adherence therapy for people with schizophrenia. European multicentre randomised controlled trial. Br. J. Psychiatry 189, 508-514 (2006). (Pubitemid 44876869)
42. Bigelow DA, McFarland BH, Gareau MJ, Young DJ. Implementation and effectiveness of a bed reduction project. Comm. Men. Health J. 27, 125-133 (1991).
43. Bond GR, Miller LD, Krumwied RD et al. Assertive case-management in three CMHCs: a controlled study. Hosp. Comm. Psychiatry 39, 411-418 (1988). (Pubitemid 18095711)
44. Bond GR, Witheridge TF, Wasmer D et al. A comparison of two crisis housing alternatives to psychiatric hospitalization. Hosp. Comm. Psychiatry 40(2), 177-183 (1989). (Pubitemid 19062732)
45. Glick ID, Fleming L, DeChillo N et al. A controlled study of transitional day care for nonchronically-ill patients. Am. J. Psychiatry 143, 1551-1556 (1986). (Pubitemid 17196198)
46. Linszen D, Dingemans P, Van Der Does JW et al. Treatment, expressed emotion, and relapse in recent onset schizophrenic disorders. Psychol. Med. 26, 333-342 (1996). (Pubitemid 26075206)
47. Xiong WPM, Hu X, Wang R et al. Family-based intervention for schizophrenic patients in China. A randomised controlled trial. Br. J. Psychiatry 165, 239-247 (1994). (Pubitemid 24259351)
48. Glick ID, Clarkin JF, Haas GL, Spencer JH Jr, Chen CL. A randomized clinical trial of inpatient family intervention: VI. Mediating variables and outcome. Fam. Process 30(1), 85-99 (1991).
49. Brown CS, Wright RG, Christensen DB. Association between type of medication instruction and patients' knowledge, side effects, and compliance. Hosp. Community Psychiatry 38(1), 55-60 (1987). (Pubitemid 17230889)
50. Merinder LB, Viuff AG, Laugesen HD, Clemmensen K, Misflet S, Espensen B. Patient and relative education in community psychiatry: a randomized control trial regarding its effectiveness. Soc. Psychiatry Psychiatr. Epidemiol. 34, 287-294 (1999). (Pubitemid 29329123)
51. Anderson KH, Ford S, Robson D, Cassis J, Rodrigues C, Gray R. An exploratory, randomized controlled trial of adherence therapy for people with schizophrenia. Int. J. Ment. Health Nurs. 19, 340-349 (2010).
52. O'Donnell C, Sharkey GDL, Owens N et al. Compliance therapy: A randomized controlled trial in schizophrenia. BMJ 327, 1-4 (2003).
53. Streicker SK, Amdur M, Dincin J. Educating patients about psychiatric medications: failure to enhance compliance. Psychosoc. Rehabil. J. 4, 15-28 (1986).